N-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

Catalog No. :
ACSRBI114
CAS No. :
2096329-80-3
Molecular Formula :
C13H21BN2O2
Molecular Weight :
248.13

IUPAC Name:N-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

N-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
IUPAC NameN-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
MDL No.MFCD14585573
Molecular FormulaC13H21BN2O2
Molecular Weight248.13
SMILESCC1(C)C(C)(C)OB(C2=CC(NCC)=NC=C2)O1
InChI KeyAHGSFGUPLBRJGX-UHFFFAOYSA-N
Synonym2-Pyridinamine, N-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;N-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine
CAS No.2096329-80-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSRBI114 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSRBI114 route product structure diagram
    ACSRBI1142096329-80-3
Inquiry

2. ACSRBI114 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWXLI084 route compound structure diagram
    ACWXLI084458532-82-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSRBI114 route product structure diagram
    ACSRBI1142096329-80-3
Inquiry

Comments (0)